Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) have earned an average recommendation of “Buy” from the seven analysts that are currently covering the stock, MarketBeat reports. Seven investment analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have issued ratings on the stock in […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) shares were up 5.2% on Monday . The stock traded as high as $28.58 and last traded at $28.46. Approximately 208,472 shares changed hands during mid-day trading, a decline of 71% from the average daily volume of 708,890 shares. The stock had previously closed at $27.06. Analyst […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Free Report)‘s stock had its “outperform” rating reissued by research analysts at Wedbush in a research report issued to clients and investors on Thursday, Benzinga reports. They presently have a $38.00 price objective on the stock. Wedbush’s price objective indicates a potential upside of 43.40% from the stock’s current price. […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Free Report)‘s stock had its “outperform” rating reissued by equities research analysts at Wedbush in a report released on Thursday, Benzinga reports. They presently have a $38.00 price target on the stock. Wedbush’s target price indicates a potential upside of 43.40% from the company’s current price. Other research analysts also […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has received an average recommendation of “Buy” from the six research firms that are covering the firm, MarketBeat reports. Six research analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the stock in the last […]